Staging for NAFLD can now be performed by a combination of radiological and laboratory techniques, greatly reducing the requirement for invasive liver biopsy, finds March's issue of the Alimentary Pharmacology & Therapeutics.
A recent study in February's issue of the Alimentary Pharmacology & Therapeutics investigates adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
Epidermal growth factor receptor is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of progression in Barrett's, reports January's American Journal of Gastroenterology.
This month's issue of the American Journal of Gastroenterology investigates the incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population.
A recent study in the Alimentary Pharmacology & Therapeutics investigates the efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab.